Kerala DCA Writes To NPPA To Bring Erythropoietin Injection Under Price Control

Chennai : Following a series of raid conducted in 23 discount medical shops in Manjeri Taluk in Malappuram district in Kerala, the state drugs control department has written to the national pharmaceutical pricing authority (NPPA) to bring erythropoietin injection, used for kidney patients, under price control.

This drug is widely used by kidney and cancer patients in the districts, but shop owners are charging huge margin putting the poor patients into distress.

“Since the drug is out of price control, drug retailers and distributors are charging huge amount for one vial of 400 mg. More than one company is manufacturing the drug and supplied to different distributors with MRP above Rs 1,500. But this is sold to the hospitals and medical shops for Rs 250 or Rs 260. The hospital and community pharmacies gain exorbitant profit out of one vial”, says Dr. M Nishith, drug inspector at Malappuram.

The regulator said erythropoietin injection is widely used for dialysis patients, but it is sold without price control. Different prices are charged by different medical shops. Finding that the drug is an essential drug for kidney patients and cancer patients, he wrote to the state drug regulator for recommending it to the national drug price regulator for fixing a ceiling price for it. Dr. Nishith said several multinational companies manufacture the drug and their products are available in Kerala.

In another development, the drug inspector’s raid in 23 medical shops in Manjeri has brought out a hidden fact that the discount pharmacies, medical shops who display discount boards to attract customers, are not giving the discounts to the customers. Some chain pharmacies announce a discount of 10% to 80% to all categories of medicines, but it is found that such discount is not effected in actual prices.  He said this issue was raised by a member of the Taluk Development Committee, followed by it his office conducted the raid. Reports have been sent to the state drug controller for action.

The major flaw the regulators saw in the dealings of the medical shop owners is that some special category medicines which are out of the DPCO are sold at high prices and earn huge margins. The drug inspector said some manufacturing companies are changing the ingredients of the formulation in order to skip the DPCO for earning huge profit. He said further raids have been planned to conduct in other talukas such as Ponnani, Perinthalmanna, Thiroorangadi and Nilambur next week.

  • Related Posts

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad